A patient's blood T cells are genetically modified to express receptor molecules to detect and eradicate cancer cells. In the top figure, T cells are engineered to express the chimeric antigen receptor (CAR); in the bottom figure the T cell receptor (TCR).
Client: Kite Pharma, Inc., Santa Monica (CA, USA)
